Cebu City—Patients and individuals in need of world-class healthcare services from Cebu and its nearby provinces now have improved access to–and can readily benefit from–top-notch medical laboratory facilities following the opening of Visayas Medical Hospital (VMH) Laboratory on April 3, 2024.
AppleOne Medical Group (AMG), the healthcare arm of the AppleOne Group of companies which owns the Visayas Medical Hospital, spearheaded the ribbon-cutting ceremony to formally open the laboratory.
The milestone reinforces the group’s commitment to bring in world-class brands and build globally-competitive facilities in VisMin, and is part of AMG’s strengthened partnership with Singapore Diagnostics (SGD). SGD will fully operate the laboratory, both inpatient and outpatient, through their well-trained medical technologists and laboratory specialists.
With its groundbreaking collaboration with SGD, VisayasMed Laboratory further elevates healthcare for Cebuanos, now with the capacity to accommodate up to 1,000 patients a day.
Offering over 450 cutting-edge tests, global quality laboratory standards, faster results, fully automated operations, and specialized training for scientists and medical technologists, this partnership heralds a new era of excellence in healthcare.
VisayasMed Hospital, formerly Visayas Community Medical Center, boasts nearly 70 years of healthcare excellence, delivering top-tier medical services having a comprehensive range of departments including family medicine, pediatrics, internal medicine, surgery, obstetrics and gynecology, as well as specialized services in dermatology, psychiatry, ophthalmology, and anesthesiology.
Moreover, SGD is the leading laboratory service provider in the Philippines and the flagship of Pathology Asia, setting global standards. It is the first Philippine laboratory accredited by the College of American Pathologists (CAP). SGD is a powerhouse in healthcare as it has been awarded Diagnostics Provider of the Year by Healthcare Asia twice, and has been recognized for Service Innovation and Employee Engagement in 2024. With over 450 professionals across 47 locations nationwide, processing laboratory tests for over 600 hospitals, clinic labs, and healthcare institutions in the Philippines, and serving up to 100,000 patients every month, SGD is a top player in Philippine laboratories.
“By teaming up with VisayasMed Hospital, we’re able to empower and provide Cebuanos with expanded access to a diverse array of top-notch laboratory tests without having the need to travel to Manila or overseas,” stated Ritche Joseph Manuel D. Evidente, President and CEO of Singapore Diagnostics.
In line with AMG’s commitment to excellence, the VisayasMed Lab has the capacity to serve up to 1,000 patients a day, ensuring timely and efficient healthcare delivery. With its unwavering dedication to providing quality healthcare, VisayasMed Hospital remains a trusted institution in the Cebuano community and beyond.
“AppleOne invests in hospitals and facilities, and partners with prestigious companies such as Singapore Diagnostics because we see how important investing in quality healthcare is. This is our way of helping elevate the quality of life of people in Cebu and the VisMin region,” said AppleOne CEO and President Ray Go Manigsaca.
Singapore Diagnostics (SGD) has grown to be among the largest laboratories in the Philippines. Processing laboratory tests for over 300 hospitals, clinic labs and healthcare institutions in the Philippines, SGD serves up to 50,000 patients every month.
Through this partnership, formally signed in April, 2023, VisayasMed Hospital will be able to carry out its main goal of providing a holistic patient experience by offering a more convenient and personalized approach to healthcare as SGD is known for its global expertise and technology. In addition to its mission to provide world class laboratory services, SGD also aims to become a well-equipped training venue for the best scientists of Cebu for the continuous improvement of medical services and quality healthcare.
